Literature DB >> 9222962

The effects of genotype and infant weight on adult plasma levels of fibrinogen, factor VII, and LDL cholesterol are additive.

J A Henry1, M Bolla, C Osmond, C Fall, D J Barker, S E Humphries.   

Abstract

High circulating levels of cholesterol, particularly low density lipoprotein (LDL) cholesterol and the clotting factors fibrinogen and factor VII, are associated with increased risk of myocardial infarction. Variations in the plasma levels of these factors are determined in part by polymorphisms in the genes concerned and also by weight at 1 year (infant weight). We have looked at the possibility of interactions between these genetic factors and infant weight in a sample of 290 men and 192 women from Hertfordshire using the beta-fibrinogen G/A-455, factor VII R353Q, and ApoE polymorphisms. The rare allele frequencies of the three polymorphisms were 0.19 for beta-fibrinogen, 0.10 for factor VII, and 0.07 and 0.13 for the 2 and 4 alleles of ApoE, and these frequencies were not different in subjects of different infant weight. In this sample, the polymorphisms showed the expected effects on plasma levels of fibrinogen, factor VII, and LDL cholesterol. The A-455 allele was associated with higher fibrinogen levels but the effect was only statistically significant in women (p = 0.003). The R353 allele was associated with higher factor VII activity in both men and women (p < 0.0001 for both). The ApoE2 allele was associated with lower levels of LDL cholesterol (p = 0.03 in men, p = 0.006 in women), while the ApoE4 allele was associated with higher levels (p < 0.001 in men, not significant in women). In this sample of men and women the effect of low infant weight was only associated with significant effects on fibrinogen and LDL cholesterol in the group of men (p = 0.005 and p = 0.008 respectively). Compared with the E3E3 subjects, the LDL lowering effect of the E2 allele and the raising effect of the E4 allele was greater in those with low infant weight compared with those with high infant weight (low v high infant weight for E2: 12.7% v 9.4%; for E4 12.7% v 8.5%). Although in this sample the interactive effect did not reach statistical significance, the additive effect of ApoE genotype and low infant weight on determining plasma LDL cholesterol levels, if confirmed, may be of relevance in determining a person's future risk of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222962      PMCID: PMC1050994          DOI: 10.1136/jmg.34.7.553

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  33 in total

1.  Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

Authors:  T W Meade; S Mellows; M Brozovic; G J Miller; R R Chakrabarti; W R North; A P Haines; Y Stirling; J D Imeson; S G Thompson
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

2.  Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

Authors:  J E Hixson
Journal:  Arterioscler Thromb       Date:  1991 Sep-Oct

Review 3.  Fetal nutrition and cardiovascular disease in adult life.

Authors:  D J Barker; P D Gluckman; K M Godfrey; J E Harding; J A Owens; J S Robinson
Journal:  Lancet       Date:  1993-04-10       Impact factor: 79.321

4.  Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease.

Authors:  A Lane; J K Cruickshank; J Mitchell; A Henderson; S Humphries; F Green
Journal:  Atherosclerosis       Date:  1992-05       Impact factor: 5.162

5.  A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals.

Authors:  F Green; C Kelleher; H Wilkes; A Temple; T Meade; S Humphries
Journal:  Arterioscler Thromb       Date:  1991 May-Jun

6.  Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study.

Authors:  P Y Scarabin; L Bara; S Ricard; O Poirier; J P Cambou; D Arveiler; G Luc; A E Evans; M M Samama; F Cambien
Journal:  Arterioscler Thromb       Date:  1993-06

7.  Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease.

Authors:  F M van Bockxmeer; C D Mamotte
Journal:  Lancet       Date:  1992-10-10       Impact factor: 79.321

8.  Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.

Authors:  J Dallongeville; S Lussier-Cacan; J Davignon
Journal:  J Lipid Res       Date:  1992-04       Impact factor: 5.922

9.  Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein.

Authors:  U Beisiegel; W Weber; G Bengtsson-Olivecrona
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life.

Authors:  D J Barker; T W Meade; C H Fall; A Lee; C Osmond; K Phipps; Y Stirling
Journal:  BMJ       Date:  1992-01-18
View more
  2 in total

1.  Childhood body mass index and adult pro-inflammatory and pro-thrombotic risk factors: data from the New Delhi birth cohort.

Authors:  Ramakrishnan Lakshmy; Caroline Hd Fall; Harshpal Singh Sachdev; Clive Osmond; Dorairaj Prabhakaran; Sushant Dey Biswas; Nikhil Tandon; Siddharth Ramji; Kolli Srinath Reddy; David Jp Barker; Santosh K Bhargava
Journal:  Int J Epidemiol       Date:  2010-07-26       Impact factor: 7.196

2.  Relationship of APOA5, PPARγ and HL gene variants with serial changes in childhood body mass index and coronary artery disease risk factors in young adulthood.

Authors:  Lakshmy Ramakrishnan; Harshpal S Sachdev; Meenakshi Sharma; Ransi Abraham; Swami Prakash; Dileep Gupta; Yogendra Singh; Seema Bhaskar; Shikha Sinha; Giriraj R Chandak; Kolli S Reddy; Bhargava Santosh
Journal:  Lipids Health Dis       Date:  2011-05-08       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.